REBECCA MONTGOMERY: Open Payments
NPI 1184234262 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 26 payments from 6 companies in 2025. Trend: 2023 $580 · 2024 $533 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $237 |
| Alkermes, Inc. | 4 | $150 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| Supernus Pharmaceuticals, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: UZEDY, LYBALVI, INGREZZA, Qelbree, REXULTI, AUSTEDO XR, ARISTADA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
